Dilip Kaul
12Patents
7h-index
20Co-inventors
62Inventor score
Filing activity: Mar 13, 1995 → May 10, 2013
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US5484801A | Pharmaceutical composition for inhibiting HIV protease | Chemistry; Metallurgy | 91 | Expired |
| US6008192A | Hydrophilic binary systems for the administration of lipophilic compounds | Emerging Cross-Sectional Technologies | 90 | Expired |
| US5948436A | Pharmaceutical composition | Human Necessities | 65 | Expired |
| US5725878A | Pharmaceutical composition comprising HIV protease inhibiting compounds | Human Necessities | 42 | Expired |
| US6232333A | Pharmaceutical composition | Human Necessities | 23 | Expired |
| US6458818B1 | Pharmaceutical composition | Human Necessities | 10 | Expired |
| US6284767A | Retroviral protease inhibiting compounds | Chemistry; Metallurgy | 7 | Expired |
| US6911214B2 | Flavoring systems for pharmaceutical compositions and methods of making such compositions | Human Necessities | 3 | Expired |
| US5876749A | Pharmaceutical composition | Human Necessities | 2 | Expired |
| US8501219B2 | Flavoring systems for pharmaceutical compositions and methods of making such compositions | Human Necessities | 1 | Active |
| US8895051B2 | Flavoring systems for pharmaceutical compositions and methods of making such compositions | Human Necessities | 0 | Active |
| US6521651B1 | Pharmaceutical composition | Human Necessities | 0 | Expired |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.